On the Role of Molecular Tumor Profiling in Breast Cancer: 2023 KU Breast Cancer Year in Review
Dr Lajos Pusztai, MD, DPhil from Yale School of Medicine comments on the use of molecular tumor profiling in breast cancer: Finding actionable, targetable mutations in PI3K, ESR, BRCA, and others; ctDNA monitoring for molecular recurrence in early breast cancer.